Menu
GeneBe

TKT

transketolase

Basic information

Region (hg38): 3:53224711-53256052

Links

ENSG00000163931NCBI:7086OMIM:606781HGNC:11834Uniprot:P29401AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • transketolase deficiency (Strong), mode of inheritance: AR
  • transketolase deficiency (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Short stature, developmental delay, and congenital heart defectsARCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Musculoskeletal; Neurologic27259054

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TKT gene.

  • not provided (30 variants)
  • Inborn genetic diseases (25 variants)
  • Transketolase deficiency (11 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TKT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
8
clinvar
6
clinvar
14
missense
32
clinvar
4
clinvar
2
clinvar
38
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
non coding
2
clinvar
6
clinvar
8
Total 0 1 33 14 14

Variants in TKT

This is a list of pathogenic ClinVar variants found in the TKT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-53225833-C-G not specified Uncertain significance (Aug 23, 2021)2246877
3-53225835-G-T See cases Uncertain significance (Mar 21, 2022)1690595
3-53225838-T-C Benign (Dec 31, 2019)719636
3-53225846-T-C Benign (Dec 31, 2019)720422
3-53225857-G-A not specified Uncertain significance (Nov 10, 2023)3177701
3-53225869-G-T not specified Uncertain significance (Jul 05, 2023)2609647
3-53225883-A-G not specified Uncertain significance (Jan 30, 2024)3177700
3-53225911-A-T not specified Uncertain significance (Jun 06, 2023)2518808
3-53225980-G-A Transketolase deficiency Benign (Sep 10, 2021)1342213
3-53226761-T-C not specified Uncertain significance (Apr 22, 2022)3177699
3-53226803-C-T not specified Uncertain significance (Apr 07, 2022)2341679
3-53226848-A-T Transketolase deficiency Uncertain significance (Jan 06, 2021)2441997
3-53228076-G-A not specified Uncertain significance (Oct 19, 2021)2255834
3-53228089-C-T Transketolase deficiency Uncertain significance (Jun 01, 2018)1033727
3-53228090-G-C TKT-related disorder Likely benign (Jun 08, 2023)773673
3-53228109-C-A not specified Uncertain significance (Apr 25, 2022)2285348
3-53228116-C-T not specified Uncertain significance (Dec 17, 2021)2343492
3-53228149-C-T not specified Uncertain significance (Nov 07, 2022)2323186
3-53228287-C-T Uncertain significance (Apr 03, 2019)1308341
3-53228343-C-T not specified Uncertain significance (May 10, 2022)2285633
3-53229019-G-C Likely benign (Nov 18, 2017)725159
3-53229049-G-A Likely benign (May 31, 2018)748504
3-53229096-T-C Benign (Dec 31, 2019)789135
3-53229118-C-T Likely benign (May 23, 2018)717617
3-53229130-G-A Likely benign (Aug 05, 2018)762214

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TKTprotein_codingprotein_codingENST00000423516 1531346
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.006750.9931257100381257480.000151
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.663063990.7660.00002504152
Missense in Polyphen126188.460.668581904
Synonymous-0.4271741671.040.00001151237
Loss of Function3.31927.90.3230.00000128344

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003040.000304
Ashkenazi Jewish0.00009920.0000992
East Asian0.0004350.000435
Finnish0.000.00
European (Non-Finnish)0.0001860.000185
Middle Eastern0.0004350.000435
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. {ECO:0000269|PubMed:27259054}.;
Disease
DISEASE: Short stature, developmental delay, and congenital heart defects (SDDHD) [MIM:617044]: An autosomal recessive syndrome characterized by short stature, developmental delay, intellectual disability and congenital heart defects including ventricular septal defect, atrial septal defect and patent foramen ovale. Cataract and uveitis are observed in some patients. {ECO:0000269|PubMed:27259054}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Pentose phosphate pathway - Homo sapiens (human);Warburg Effect;Pentose Phosphate Pathway;Glucose-6-phosphate dehydrogenase deficiency;Ribose-5-phosphate isomerase deficiency;Transaldolase deficiency;Pentose Phosphate Pathway;Pentose phosphate pathway (hexose monophosphate shunt);Metabolism of carbohydrates;Insulin effects increased synthesis of Xylulose-5-Phosphate;Metabolism;Pentose phosphate cycle;pentose phosphate pathway (non-oxidative branch);pentose phosphate pathway;EGFR1;Integration of energy metabolism (Consensus)

Recessive Scores

pRec
0.459

Intolerance Scores

loftool
0.172
rvis_EVS
-0.49
rvis_percentile_EVS
22.7

Haploinsufficiency Scores

pHI
0.705
hipred
Y
hipred_score
0.756
ghis
0.548

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.885

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tkt
Phenotype
liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; renal/urinary system phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan);

Gene ontology

Biological process
xylulose biosynthetic process;pentose-phosphate shunt;pentose-phosphate shunt, non-oxidative branch;regulation of growth;glyceraldehyde-3-phosphate biosynthetic process
Cellular component
nucleoplasm;peroxisome;cytosol;nuclear body;nuclear speck;vesicle;myelin sheath;extracellular exosome
Molecular function
transketolase activity;protein binding;protein homodimerization activity;metal ion binding;cofactor binding